| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.59B | — | +2.5% |
| R&D Expense | $133.0M | — | -8.9% |
| SG&A Expense | $562.0M | — | -2.6% |
| Pre-tax Income | $1.27B | — | +127.1% |
| Income Tax | $336.0M | — | +121.1% |
| Net Income | $930.0M | — | +131.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $6.70B | +0.8% | -0.2% |
| Inventory | $4.87B | -1.7% | -5.7% |
| Current Assets | $28.59B | +51.9% | +69.8% |
| Total Assets | $50.90B | +24.5% | +33.6% |
| Current Liabilities | $13.41B | -3.3% | +6.5% |
| Long-term Debt | $15.41B | +185.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $500.0M | — | -29.5% |
| Investing Cash Flow | $1.04B | — | +434.8% |
| Financing Cash Flow | $9.52B | — | +1997.0% |
| +158.2% |
| Stockholders' Equity | $19.31B | +2.5% | +13.3% |